Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD

Respirology

Volumn 20, Issue 7, 2015, Pages 1089-1095

  Barberan Garcia, Anael ^a,b,c   Rodríguez, Diego Agustín ^c,d   Blanco, Isabel ^a,b,c   Gea, Joaquim ^c,d   Torralba, Yolanda ^a,c   Arbillaga Etxarri, Ane ^e,f   Barberà, Joan Albert ^a,b,c   Vilarõ, Jordi ^g   Roca, Josep ^a,b,c   Orozco Levi, Mauricio ^c,d,h  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g UNIVERSITAT RAMON LLULL   (Spain)

^h Cardiovascular Foundation from Colombia Floridablanca   (Colombia)

Author keywords

aerobic exercise; chronic obstructive pulmonary disease; exercise test; exercise therapy; iron metabolism disorder

Indexed keywords

AEROBIC CAPACITY; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; CYCLING; ENDURANCE TRAINING; EXHAUSTION; FEMALE; HUMAN; IRON DEFICIENCY; MALE; OBSERVATIONAL STUDY; OXYGEN CONSUMPTION; PATIENT CODING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY REHABILITATION; SAMPLE SIZE; TREATMENT RESPONSE; BLOOD; COMPLICATION; EXERCISE TEST; EXERCISE TOLERANCE; IRON METABOLISM DISORDER; KINESIOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

IRON;

AGED; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HUMANS; IRON; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84941600451     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12591     Document Type: Article

References (32)

1. Robinson JC, Graham BB, Rouault TC, Tuder RM,. The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 2014; 51: 721-729.
2. Williams MH,. Dietary supplements and sports performance: minerals. J. Int. Soc. Sports Nutr. 2005; 2: 43-49.
3. Zhu YI, Haas JD,. Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial. J. Appl. Physiol. 1998; 84: 1768-1775.
4. Haas JD, Brownlie T,. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J. Nutr. 2001; 131 (2S-2): 676S-688S.
5. Brownlie T 4th, Utermohlen V, Hinton PS, Giordano C, Haas JD,. Marginal iron deficiency without anaemia impairs aerobic adaptation among previously untrained women. Am. J. Clin. Nutr. 2002; 75: 734-742.
6. Brownlie T 4th, Utermohlen V, Hinton PS, Haas JD,. Tissue iron deficiency without anaemia impairs adaptation in endurance capacity after aerobic capacity in previously untrained women. Am. J. Clin. Nutr. 2004; 79: 437-443.
7. Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD, et al., Iron status in patients with chronic heart failure. Eur. Heart J. 2013; 34: 827-834.
8. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak L, Filippatos G, McMurray JJ, et al., Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur. Heart J. 2010; 31: 1872-1880.
9. Ruiter G, Lankhorst S, Boonstra A, Postmus PE, Zweegman S, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A,. Iron deficiency is common in idiopathic pulmonary hypertension. Eur. Respir. J. 2011; 37: 1386-1391.
10. Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G,. Anaemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anaemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm. Med. 2014; 14: 24.
11. Comeche Casanova L, Echave-Sustaeta JM, García-Luján R, Albarrán Lozano I, Alonso González P, Llorente Alonso ML,. Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables. Arch. Bronconeumol. 2013; 49: 383-387.
12. Boutou AK, Stanopoulos I, Pitsiou GG, Kontakiotis T, Kyriazis G, Sichletidis L, Argyropoulou P,. Anaemia of chronic disease in chronic obstructive pulmonary disease; a case-control study of cardiopulmonary exercise responses. Respiration 2011; 83: 237-245.
13. Rabinovich RA, Bastos R, Ardite E, Llinàs L, Orozco-Levi M, Gea J, Vilarõ J, Barberà JA, Rodríguez-Roisin R, Fernández-Checa JC, et al., Mitochondrial dysfunction in COPD patients with low body mass index. Eur. Respir. J. 2007; 29: 643-650.
14. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, et al., ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2014; 189: e15-62.
15. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD-C, et al., An Official American Thoracic Society/European Respiratory Society Statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013; 188: e13-64.
16. Barberan-Garcia A, Vogiatzis I, Solberg HS, Vilarõ J, Rodríguez DA, Garåsen HM, Troosters T, Garcia-Aymerich J, Roca J,. NEXES consortium. Effects and barriers to deployment of telehealth wellness programs for chronic patients across 3 European countries. Respir. Med. 2014; 108: 628-637.
17. Vestbo J, Hurd SS, Agustí A, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al., Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347-365.
18. Roca J, Whipp BJ, Agustí AGN, Anderson SD, Casaburi R, Cotes JE, Donner CF, Estenne M, Folgering H, Higenbottam TW, et al., Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur. Respir. J. 1997; 10: 2662-2689.
19. Gimeno-Santos E, Rodríguez DA, Barberan-Garcia A, Blanco I, Vilarõ J, Torralba Y, Rodriguez-Roisin R, Barberà JA, Roca J, Garcia-Aymerich J,. Endurance exercise training improves heart rate recovery in patients with COPD. COPD 2014; 11: 190-196.
20. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six -minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111-117.
21. Vilarõ J, Gimeno E, Sánchez-Férez N, Hernando C, Díaz I, Ferrerc M, Roca J, Alonso J,. Daily living activity in chronic obstructive pulmonary disease: validation of the Spanish version and comparative analysis of 2 questionnaires. Med. Clin. (Barc) 2007; 129: 326-332.
22. Jones PW, Quirk FH, Baveystock CM, Littlejohns P,. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992; 145: 1321-1327.
23. Okonko DO, Grzweslo A, Witkowki T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, et al., Effect of intravenous iron sucrose on exercise tolerance in anaemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J. Am. Coll. Cardiol. 2008; 51: 103-112.
24. Puente-Maestu L, Villar F, de Miguel J, Stringer WW, Sanz ML, de Pedro JG, Martínez-Abad Y,. Clinical relevance of constant power exercise duration changes in COPD. Eur. Respir. J. 2009; 34: 340-345.
25. de Silva R, Rigby AS, Witte KK, Nikitin NP, Tin L, Goode K, Bhandari S, Clark AL, Cleland JG,. Anaemia, renal dysfunction and their interaction in patients with chronic heart failure. Am. J. Cardiol. 2006; 98: 391-398.
26. Klipt IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, et al., Iron deficiency in chronic heart failure: an international pooled analysis. Am. Heart J. 2013; 165: 575-582.
27. Looker A, Dallman P, Carroll M, Gunter E, Johnson C,. Prevalence of iron deficiency in the United States. JAMA 1997; 277: 973-976.
28. Skikne BS,. Serum transferring receptor. Am. J. Hematol. 2008; 83: 872-875.
29. Wians FH Jr, Urban JE, Keffer JH, Kroft SH,. Discriminating between iron deficiency anaemia and anaemia of chronic disease using traditional indices of iron status vs transferring receptor concentration. Am. J. Clin. Pathol. 2001; 115: 112-118.
30. Punnonen K, Irjala K, Rajamaki A,. Serum transferring receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89: 1052-1057.
31. Holloszy J,. Adaptations of skeletal muscle to endurance exercise. Med. Sci. Sports 1975; 7: 155-164.
32. Holloszy J, Coyle E,. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 1984; 56: 831-838.